Tumor necrosis factor promoter polymorphisms in patients with rheumatoid arthritis in Taiwan

Journal of Rheumatology

Volumn 28, Issue 8, 2001, Pages 1788-1792

  Yen, J H ^a   Chen, C J ^a   Tsai, W C ^a   Lin, C H ^a   Ou, T T ^a   Wu, C C ^a   Liu, H W ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Polymorphism; Rheumatoid arthritis; Tumor necrosis factor

Indexed keywords

HLA DR4 ANTIGEN; TUMOR NECROSIS FACTOR;

ARTICLE; CONTROLLED STUDY; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS; SYMPTOM; TAIWAN;

ARTHRITIS, RHEUMATOID; GENE FREQUENCY; HUMANS; PHENOTYPE; POLYMORPHISM, GENETIC; PREVALENCE; PROMOTER REGIONS (GENETICS); TAIWAN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034903859     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Molecular relationships between the class II HLA antigens and susceptibility to rheumatoid arthritis
2. HLA-DRB1 genotyping in patients with rheumatoid arthritis in Taiwan
3. Synovial localization of tumor necrosis factor in patients with rheumatoid arthritis
4. Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage
5. Role of pro-inflammatory cytokines in rheumatoid arthritis
6. Role of cytokines in rheumatoid arthritis
7. TNF, apoptosis and autoimmunity: A common thread?
8. Transgenic mice expression human tumor necrosis factor: A predictive genetic model of arthritis
9. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial
10. Repeated therapy with monoclonal antibody to tumor necrosis factor alpha (cA2) in patients with rheumatoid arthritis
11. Allele typing of human TNFA 5′-flanking region using polymerase chain reaction-preferential homoduplex formation assay (PCR-PHFA): Linkage disequilibrium with HLA class I and class II genes in Japanese
12. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter
13. Genetic variability in the TNFa promoter is not associated with type II diabetes mellitus (NIDDM)
14. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNFa and TNFβ by human mononuclear cells: A possible link to insulin-dependent diabetes mellitus
15. A genetic marker of high TNFa production in heart transplant recipients
16. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles
17. Tumor necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosis
18. Increased frequency of the uncommon allele of a tumor necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus
19. Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population
20. A TNFa promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis
21. The -308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27
22. Association of different tumor necrosis factor alpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals
23. Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus
24. Tumor necrosis factor gene polymorphisms in ankylosing spondylitis
25. Polymorphism within the tumor necrosis factor a promoter region in patients with ankylosing spondylitis
26. The TNF2 allele does not contribute towards susceptibility to systemic lupus erythematosus
27. Polymorphisms in the 5-flanking region of tumor necrosis factor-alpha gene in patients with rheumatoid arthritis
28. Allele-specific quantification of TNFA transcripts in rheumatoid arthritis
29. Single base polymorphism in the human tumor necrosis factor alpha gene detectable by NcoI restriction of PCR product
30. A common functional polymorphism (C→A substitution at position -863) in the promoter region of the tumor necrosis factor a (TNFa) gene associated with reduced circulating levels of TNFa
31. On estimating the relation between blood group and disease
32. The estimation and significance of the logarithm of a ratio of frequencies
33. A polymorphic variation in a putative regulation box of the TNFA promoter region
34. Identification and characterization of a novel repressor site in the human tumor necrosis factor a gene
35. Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor a promoter in primary macrophages
36. Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation
37. Analysis of the polymorphism of the tumor necrosis factor (TNF) gene and promoter and of circulating TNF-alpha levels in heart-transplant patients suffering or not suffering from severe rejection
38. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria
39. Polymorphism of the 5′-flanking region of the human tumor necrosis factor a gene in Japanese
40. Tumor necrosis factor gene polymorphisms in rheumatoid arthritis: Association with susceptibility to, or severity of, disease?
41. Polymorphism at the TNF loci in rheumatoid arthritis
42. TNF-alpha gene polymorphism does not affect the clinical and radiological outcome of rheumatoid arthritis